🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU)

Found 20 matching trials

Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)

PHASE3

The purpose of this trial is to investigate the efficacy of cetuximab in co...

Status

Completed

Location

Research Site

Start Date

2004-12

Trial ID

NCT00122460

Treatments Being Tested

Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU)Platinum (Cisplatin or Carboplatin) + 5-FU

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

PHASE3

The purpose of this study is to evaluate the safety and efficacy of the com...

Status

Withdrawn

Location

Multiple Locations

Start Date

2017-12-15

Trial ID

NCT03342352

Treatments Being Tested

Nivolumab Epacadostat Placebo Carboplatin Cisplatin Cetuximab 5-Fluorouracil

A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)

PHASE3

Participants with recurrent or metastatic (R/M) squamous cell cancer of the...

Status

Completed

Location

Multiple Locations

Start Date

2015-03-19

Trial ID

NCT02358031

Treatments Being Tested

Pembrolizumab Cisplatin Carboplatin 5-FU Cetuximab

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

PHASE2

The purpose of this study is to find out if lower doses of radiation may he...

Status

Recruiting

Location

Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities)

Start Date

2022-08-04

Trial ID

NCT05491512

Treatments Being Tested

18 F-FMISO PET/CT Radiation Cisplatin Carboplatin 5-fluorouracil

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

PHASE1

The purpose of this study is to learn about the safety and effects of the s...

Status

Terminated

Location

Highlands Oncology Group

Start Date

2024-12-10

Trial ID

NCT06704724

Treatments Being Tested

PF-07985045 Gemcitabine Nab-paclitaxel Cetuximab Fluorouracil Oxaliplatin Leucovorin Bevacizumab Pembrolizumab Sasanlimab pemetrexed Cisplatin Paclitaxel Carboplatin PF-07284892

A Study of ASP3082 in Adults With Advanced Solid Tumors

PHASE1

This is an open-label study. This means that people in this study and clini...

Status

Recruiting

Location

City of Hope National Medical Center

Start Date

2022-06-08

Trial ID

NCT05382559

Treatments Being Tested

Setidegrasib Cetuximab Leucovorin Oxaliplatin Fluorouracil Irinotecan Nanoparticle albumin-bound-paclitaxel Gemcitabine Docetaxel Pembrolizumab Cisplatin Carboplatin Pemetrexed Liposomal Irinotecan

Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

PHASE3

The main purpose of this study is to compare nivolumab and ipilimumab with ...

Status

Completed

Location

Local Institution - 0134

Start Date

2016-10-05

Trial ID

NCT02741570

Treatments Being Tested

Nivolumab Ipilimumab Cetuximab/Erbitux Cisplatin/Platinol Carboplatin/Paraplatin Fluorouracil/Adrucil

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

PHASE2

The purpose of this study is to compare the progression-free survival of pa...

Status

Completed

Location

University of Arkansas for Medical Sciences

Start Date

2013-10-14

Trial ID

NCT01836029

Treatments Being Tested

VTX-2337 Carboplatin Cisplatin 5-fluorouracil Placebo

Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

PHASE3

This is a randomized, open-label, multi-center, 3-arm, global Phase III stu...

Status

Completed

Location

Research Site

Start Date

2015-10-15

Trial ID

NCT02551159

Treatments Being Tested

MEDI4736 Tremelimumab MEDI4736+Tremelimumab Cetuximab 5-fluorouracil (5FU)Cisplatin Carboplatin

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

PHASE2

This study evaluates the efficacy of the new docetaxel-cisplatin-cetuximab ...

Status

Completed

Location

Institut Sainte Catherine

Start Date

2014-10-10

Trial ID

NCT02268695

Treatments Being Tested

Cisplatin 5-Fluorouracile Docetaxel Cetuximab granulocyte colony-stimulating factor (G-CSF)

Previous Next